Preview

Лечащий Врач

Расширенный поиск

Сердечно-сосудистые заболевания и первичный рак молочной железы: коморбидность и модифицируемые факторы риска

Полный текст:

Аннотация

Рассмотрены факторы риска развития первичного рака молочной железы (РМЖ). Анализ показывает, что в женской популяции сердечно-сосудистые заболевания и РМЖ имеют общие модифицируемые факторы риска, что определяет перспективы дополнительных преимуществ немедикаментозных профилактических вмешательств.

Об авторах

И. В. Друк
ФГБОУ ВО ОмГМУ МЗ РФ
Россия


А. Р. Ибрагимова
ФГБОУ ВО ОмГМУ МЗ РФ
Россия


М. Р. Ибрагимова
ФГБОУ ВО ОмГМУ МЗ РФ
Россия


А. С. Лялюкова
ФГБУЗ ЗСМЦ ФМБА России
Россия


И. М. Радюкова
БУЗОО ООД
Россия


О. Ю. Кореннова
БУЗОО ГККД
Россия


И. В. Ашвиц
ФГБОУ ВО ОмГМУ МЗ РФ
Россия


Список литературы

1. Здравоохранение в России. 2017: Стат. сб. Росстат. М., 2017. 170 с.

2. Состояние онкологической помощи населению России в 2016 году / Под ред. А. Д. Каприна, В. В. Старинского, Г. В. Петровой. М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИРЦ» Минздрава России, 2017. 236 с.

3. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) // European Heart Journal. 2016; 37: 2768–2801. DOI: 10.1093/eurheartj/ehw211.

4. Муромцева Г. А., Концевая А. В., Константинов В. В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ // Кардиоваскулярная терапия и профилактика. 2014; 13 (6): 8.

5. Benjamin E. J., Blaha M. J., Chiuve S. E., Cushman M., Das S. R. et al. Оn behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2017 update: a report from the American Heart Association [published corrections appear in Circulation // Circulation. 2017; 135: e146–e603. DOI: 10.1161/CIR.0000000000000485.

6. Gernaat S. A. M., Ho P. J., Rijnberg N. et al. Risk of death from cardiovascular disease following breast cancer: a systematic review // Breast Cancer Research and Treatment. 2017; 164 (3): 537–555. DOI: 10.1007/s10549–017–4282–9.

7. Bradshaw P. T., Stevens J., Khankari N., Teitelbaum S. L. et al. Cardiovascular Disease Mortality Among Breast Cancer Survivors // Epidemiology (Cambridge, Mass). 2016; 27 (1): 6–13. DOI: 10.1097/EDE.0000000000000394.

8. Mehta L. S., Watson K. E., Barac A., Beckie Th. M. et al. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association // Circulation. 2018, February 20, 137 (8): e30-e66. DOI: 10.1161/CIR.0000000000000556.

9. Mozaffarian D., Benjamin E. J., Go A. S., Arnett D. K. et al. On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2016 update: a report from the American Heart Association [published correction appears in Circulation. 2016; 133: e599] // Circulation. 2015; 133: e38–e360. DOI: 10.1161/CIR.0000000000000350.

10. Кардиоваскулярная профилактика 2017. Национальные рекомендации. Комитет экспертов. 2017; 289 с. http://scardio.ru/content/Guidelines/Cardiovascular-prof-2017.pdf.

11. Heidemann C., Schulze M. B., Franco O. H., van Dam R. M., Mantzoros C. S., Hu F. B. Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women // Circulation. 2008; 118: 230–237. DOI: 10.1161/CIRCULATIONAHA.108.771881.

12. Mozaffarian D. Nutrition and cardiovascular and metabolic disease. In: Bonow R. O., Mann D. L., Zipes D. P., Libby P. Braunwald’s heart disease: a textbook of cardiovascular medicine. Elsevier Saunders; Philadelphia: 2015.

13. Heidemann C., Schulze M. B., Franco O. H., van Dam R. M., Mantzoros C. S., Hu F. B. Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women // Circulation. 2008; 118: 230–237. DOI: 10.1161/CIRCULATIONAHA.108.771881.

14. Hashemi S. H. B., Karimi S., Mahboobi H. Lifestyle changes for prevention of breast cancer // Electronic Physician. 2014; 6 (3): 894–905. DOI: 10.14661/2014.894–905.

15. Zheng J. S., Hu X. J., Zhao Y. M., Yang J., Li D Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies // BMJ. 2013; 346: f3706.

16. Kushi L. H., Doyle C., McCullough M., Rock C. L. et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention // CA: A Cancer Journal for Clinicians. 2012; 62: 30–67. DOI: 10.3322/caac.20140.

17. Papaioannou M. D., Koufaris C., Gooderham N. J. The cooked meat-derived mammary carcinogen 2-amino-1-methyl-6-phenylim-idazo[4,5-b]pyridine (PhIP) elicits estrogenic-like microRNA responses in breast cancer cells // Toxicol Lett. 2014; 229 (1): 9–16.

18. Knott C. S., Coombs N., Stamatakis E., Biddulph J. P. All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts // BMJ. 2015; 350: h384. DOI: 10.1136/bmj. h384.

19. Jimenez M., Chiuve S. E., Glynn R. J., Stampfer M. J. et al. Alcohol consumption and risk of stroke in women // Stroke. 2012; 43: 939–945. DOI: 10.1161/STROKEAHA.111.639435.

20. Roerecke M., Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis // Addiction. 2012; 107: 1246–1260. DOI: 10.1111/j.1360–0443.2012.03780. x.

21. Roerecke M., Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers // BMC Med. 2014; 12: 182. DOI: 10.1186/s12916–014–0182–6.

22. Roerecke M., Tobe S. W., Kaczorowski J. et al. Sex-Specific Associations Between Alcohol Consumption and Incidence of Hypertension: A Systematic Review and Meta-Analysis of Cohort Studies. Journal of the American Heart Association // Cardiovascular and Cerebrovascular Disease. 2018; 7 (13): e008202. DOI: 10.1161/JAHA.117.008202.

23. Shield K. D., Soerjomataram I., Rehm J. Alcohol Use and reast Cancer: A Critical Review. Alcoholism // Clinical and Experimental Research. 2016; 40 (6), 1166–1181. DOI: 10.1111/acer.13071.

24. Howell A., Anderson A. S., Clarke R. B., Duffy S. W. et al. Risk determination and prevention of breast cancer // Breast Cancer Res. 2014; 16: 446. DOI: 10.1186/s13058–014–0446–2.

25. Schwedhelm C., Boeing H., Hoffmann G., Aleksandrova K., Schwingshackl L. Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies // Nutrition Reviews. 2016; 74 (12): 737–748. DOI: 10.1093/nutrit/nuw045.

26. Liu Y., Colditz G. A., Rosner B., Berkey C. S. et al. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk // J Natl Cancer Inst. 2013; 105 (20): 1571–1578. DOI: 10.1093/jnci/djt213.

27. Armstrong M. E., Green J., Reeves G. K., Beral V., Cairns B. J. On behalf of the Million Women Study Collaborators. Frequent physical activity may not reduce vascular disease risk as much as moderate activity: large prospective study of women in the United Kingdom // Circulation. 2015; 131: 721–729. DOI: 10.1161/CIRCULATIONAHA.114.010296.

28. Hashemi S. H. B., Karimi S., Mahboobi H. Lifestyle changes for prevention of breast cancer // Electronic Physician. 2014; 6 (3): 894–905. DOI: 10.14661/2014.894–905.

29. Boeke C. E., Eliassen A. H., Oh H., Spiegelman D., Willett W. C., Tamimi R. M. Adolescent physical activity in relation to breast cancer risk // Breast Cancer Res Treat. 2014; 145: 715–724. DOI: 10.1007/s10549–014–2919–5.

30. Tamimi R. M., Spiegelman D., Smith-Warner S. A., Wang M. et al. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer // Am J Epidemiol. 2016 Dec 15; 184 (12): 884–893. DOI: 10.1093/aje/kww145.

31. Nelson H. D., Zakher B., Cantor A., Fu R. et al. isk Factors for Breast Cancer for Women Age 40 to 49: A Systematic Review and Meta-analysis // Ann Intern Med. 2012, May 1; 156 (9): 635–648. DOI: 10.1059/0003–4819–156–9–201205010–00006.

32. Hashemi S. H. B., Karimi S., Mahboobi H. Lifestyle changes for prevention of breast cancer // Electronic Physician. 2014; 6 (3): 894–905. DOI: 10.14661/2014.894–905.

33. Brenner D. R., Brockton N. T., Kotsopoulos J. et al. Breast cancer survival among young women: a review of the role of modifiable lifestyle factors // Cancer Causes & Control. 2016; 27: 459–472. DOI: 10.1007/s10552–016–0726–5.

34. Bruno E., Roveda E., Vitale J. et al. Effect of aerobic exercise intervention on markers of insulin resistance in breast cancer women // Eur J Cancer Care. 2018; 27: e12617. https://doi. org/10.1111/ecc.12617.

35. Муромцева Г. А., Концевая А. В., Константинов В. В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ // Кардиоваскулярная терапия и профилактика. 2014; 13 (6): 8.

36. Rosner B., Eliassen A. H., Toriola A. T., Hankinson S. E., Willett W. C., Natarajan L., Colditz G. A. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women // Breast Cancer Res Treat. 2015; 150: 643–653. DOI: 10.1007/s10549-015-3344-0.

37. Hashemi S. H., Karimi S., Mahboobi H. Lifestyle changes for prevention of breast cancer // Electron Physician. 2014 Jul 1; 6 (3): 894–905. DOI: 10.14661/2014.894–905.

38. Keum N., Greenwood D. C., Lee D. H., Kim R., Aune D., Ju W., Hu F. B., Giovannucci E. L. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies // J Natl Cancer Inst. 2015; 107: djv088. DOI: 10.1093/jnci/djv088.

39. Проект Стратегии формирования здорового образа жизни населения, профилактики и контроля неинфекционных заболеваний на период до 2025 года. Дата публикации 26.06.2017 г. https://www.gnicpm.ru/UserFiles/Strategy_draft_26062017.pdf.

40. Gray J. M., Rasanayagam S., Engel C., Rizzo J. State of the evidence 2017: an update on the connection between breast cancer and the environment // Environmental Health. 2017; 16: 94. DOI: 10.1186/s12940-017-0287-4.

41. Parada H., Bradshaw P. T., Steck S. E. et al. Postdiagnosis Changes in Cigarette Smoking and Survival Following Breast Cancer // JNCI cancer spectrum. 2017; 1 (1): pkx001. DOI: 10.1093/jncics/pkx001.

42. Kawai M., Malone K. E., Tang M.-T. C., Li C. I. Active smoking and risk of estrogen receptor positive and triple-negative breast cancer among women 20–44 years of age // Cancer. 2014; 120 (7): 1026–1034. DOI: 10.1002/cncr.28402.

43. Butler E. N., Tse C.-K., Bell M. E., Conway K., Olshan A. F., Troester M. A. Active smoking and risk of Luminal and Basal-like breast cancer subtypes in the Carolina Breast Cancer Study // Cancer causes & control: CCC. 2016; 27 (6): 775–786. DOI: 10.1007/s10552-016-0754-1.

44. Jones M. E., Schoemaker M. J., Wright L. B., Ashworth A., Swerdlow A. J. Smoking and risk of breast cancer in the Generations Study cohort // Breast Cancer Res. 2017, Nov 22; 19 (1): 118. DOI: 10.1186/s13058–017–0908–4.

45. Nyante S. J., Gierach G. L., Dallal C. M. et al. Cigarette smoking and postmenopausal breast cancer risk in a prospective cohort // British Journal of Cancer. 2014; 110 (9): 2339–2347. DOI: 10.1038/bjc.2014.132.

46. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. Клинические рекомендации РАЭ, МЗ РФ // Проблемы эндокринологии. 2016, 4, с. 60–84. DOI: 10.14341/probl201662460–84.

47. Forman J. P., Giovannucci E., Holmes M. D. et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension // Hypertension. 2007; 49: 1063–1069.

48. Shekarriz-Foumani R., Khodaie F. The correlation of plasma 25-hydroxyvitamin D deficiency with risk of breast neoplasms: a systematic review // Iran J Cancer Prev. 2016; 9: e4469. DOI: 10.17795/ijcp-4469.

49. Kim J. S., Haule C. C., Kim J. H. et al. Association between Changes in Serum 25-Hydroxyvitamin D Levels and Survival in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy // Journal of Breast Cancer. 2018; 21 (2): 134–141. DOI: 10.4048/jbc.2018.21.2.134.

50. Welsh J. Function of the vitamin D endocrine system in mammary gland and breast cancer // Mol Cell Endocrinol. 2017 Sep 15; 453: 88–95. DOI: 10.1016/j. mce.2017.04.026.

51. Sergeev I. N. Vitamin D and cellular Ca2+ signaling in breast cancer // Anticancer Res. 2012; 32: 299–302.

52. Iqbal M. U. N., Khan T. A. Association between vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: a systematic review and meta-analysis // Tumour Biol. 2017; 39: 1010428317731280. DOI: 10.1177/1010428317731280.

53. Wang D., V?lez de-la-Paz O. I., Zhai J. X. et al. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies // Tumor Biol. 2013, 34: 3509. https://doi. org/10.1007/s13277–013–0929–2.

54. Shekarriz-Foumani R., Khodaie F. The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review // Iran J Cancer Prev. 2016, Jun; 9 (3): e4469. DOI: 10.17795/ijcp-4469.

55. Stoll F., Akladios C. Y., Mathelin C. Vitamin D and breast cancer: is there a link? // Gynecol Obstet Fertil. 2013; 41: 242–50.

56. Ord??ez-Mena J. M., Sch?ttker B., Fedirko V., Jenab M. et al. Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium // Eur J Epidemiol. 2016 Mar; 31 (3): 311–23. DOI: 10.1007 / s10654–015–0040–7.

57. Welsh J. E. Vitamin D and Breast Cancer: Past and Present // Journal of Steroid Biochemistry and Molecular Biology 2018; 177: 15–20. http://dx. doi. org/10.1016/j. jsbmb.2017.07.025.

58. Chiriac V. F., Baban A., Dumitrascu D. L. Psychological stress and breast cancer incidence: a systematic review // Clujul Med. 2018; 91 (1): 18–26. DOI: 10.15386/cjmed-924.

59. Heikkil? K., Nyberg S. T., Theorell T., Fransson E. I., Alfredsson L., Bjorner J. B. et al. Work stress and risk of cancer: Meta-analysis of 5700 incident cancer events in 116,000 European men and women // BMJ. 2013; 346: f165.

60. Schoemaker M. J., Jones M. E., Wright L. B., Griffin J. et al. Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom // Breast Cancer Res. 2016, Jul 15; 18 (1): 72. DOI: 10.1186/s13058–016–0733–1.

61. Sun H. L., Dong X. X., Cong Y. J., Gan Y. et al. Depression and the risk of breast cancer: A meta-analysis of cohort studies // Asian Pac J Cancer Prev. 2015; 16: 3233–3239.

62. Aky?rek ?., Akbal E., G?ne? F. Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level // Arch Med Res. 2014; 45: 501–506.

63. Wu Y., Huang Y., Hu Y., Zhong J. et al. Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China // Herz. 2013; 38: 779–784.

64. Alam N., Khan H. I., Chowdhury A. W., Haque M. S. et al. Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction // Bangladesh Med Res Counc Bull. 2012; 38: 9–13.

65. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis // JAMA. 2002; 288: 2015–2022.

66. Humphrey L. L., Fu R., Rogers K., Freeman M., Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis // Mayo Clin Proc. 2008; 83: 1203–1212.

67. Robinson K. Low cir culating folate and vitamin b6 concentrations risk factors for stroke, peripheral vascular disease, and coronary artery disease // Circulation. 1998. Vol. 97. P. 437–443.

68. Van Beynum I. M. Hyperhomocysteinemia: a risk factor for ischemic stroke in children // Circulation. 1999. Vol. 99. P. 2070–2072.

69. Virtanen J. K. Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the kuopio ischaemic heart disease risk factors (KIHD) study // Intl. med. 2005. Vol. 257. P. 255–262.

70. Veeranna V., Zalawadiya S. K., Niraj A. et al. Homocysteine and reclassification of cardiovascular disease risk // J Am Coll Cardiol. 2011, Aug 30; 58 (10): 1025–1033.

71. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis // J Am Med Assoc. 2002; 288: 2015–2022.

72. Wald D. S., Law M., Morris J. K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis // BMJ. 2002; 325: 1202–1208.

73. Kim Y. I. Folate and carcinogenesis: Evidence, mechanisms, and implications // J Nutr Biochem. 1999; 10: 66–88.

74. Blount B. C., Mack M. M., Wehr C. M., MacGregor J. T. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neural damage // Proc Natl Acad Sci USA. 1997; 94: 3290–3295.

75. Lin J., Lee I. M., Song Y., Cook N. R. et al. Plasma homocysteine and cysteine and risk of breast cancer in women // Cancer Res. 2010; 70, 2397–2405.

76. Lewis S. Yu., Harbor R. M., Harris R., Smith G. D. Meta-analyzes of the observational and genetic associations of ies ve ve ve veir cancer of breast and breast cancer // J. Natl Cancer Inst. 2006. V. 98. № 22. P. 1607–1622.

77. Lissowska J., Gaudet M. M., Brinton L. A. et al. genetic polymorphisms in a single-carbon pathway of metabolism-and the risk of breast cancer: a control study and a meta-analysis // Int. J. Cancer. V. 120. № 12. P. 2696–2703.

78. BrAvatara V. The controversial roles of methylene tetrahydro-polymorphisms of folateductase and folic acid in the mammary gland of cancerdisease // Int. J. Food. Sci. Nutr. 2015. V. 66. № 1. P. 43–49.

79. Babyshkina N., Malinovskaya E., Nazarenko M. et al. Effect of folate-associated SNP on clinical function, response to neoadjuvant treatment and survival in pre- and postmenopauser of the breast patients // Gene. 2013. V. 518. № 2. P. 397–404.

80. Ding X. P., Feng L., Ma L. MTHFR C677T полиморфно-физм и риск рака яичников: метаанализ. Азиатский Пак // J. Cancer Prev. 2012. V. 13. № 8. P. 3937–3942.

81. Naushad S. M., Pavani A., Rupasri Y. et al. association of aberrations in a single-carbon metabolism, a molecular phenotype and cancer of breast cancer // Mol. Carcinog. 2012. V. 51. Appendix 1: E32–41.

82. Suzuki T., Matsuo K., Hirose K. et al. One-carbon me-polymorphisms associated with tabolism, and the risk of developing breast cancer // Carcinogenesis. V. 29. № 2. P. 356–362.


Рецензия

Для цитирования:


Друк И.В., Ибрагимова А.Р., Ибрагимова М.Р., Лялюкова А.С., Радюкова И.М., Кореннова О.Ю., Ашвиц И.В. Сердечно-сосудистые заболевания и первичный рак молочной железы: коморбидность и модифицируемые факторы риска. Лечащий Врач. 2019;(2):23.

For citation:


Druk I.V., Ibragimova A.R., Ibragimova M.R., Lyalyukova A.S., Radyukova I.M., Korennova O.Yu., Ashvits I.V. Cardiovascular diseases and primary breast cancer: comorbidity and modified risk factors. Lechaschi Vrach. 2019;(2):23. (In Russ.)

Просмотров: 21


Creative Commons License
Контент доступен под лицензией Attribution-NonCommercial-NoDerivatives 4.0 International.


ISSN 1560-5175 (Print)
ISSN 2687-1181 (Online)